Precigen (PGEN) Debt/Assets Ratio: History & Chart

Precigen, Inc.(PGEN)

Biotechnology · Germantown, MD

$7.59-0.15 (-1.90%)

Delayed quote: Oct 6, 2026, 3:30 PM EDT

About Precigen, Inc.

Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore, Precigen utilizes its AdenoVerse platform, a library of engineered adenovectors for gene delivery and immunotherapy applications, alongside L. lactis, a food-grade bacterium. The company also provides RheoSwitch, an inducible gene switch system offering quantitative, dose-proportionate control over target protein expression's timing and amount; kill switches, designed to selectively eliminate cell therapies within the body; tissue-specific promoters for targeted gene expression; the UltraCAR-T platform for cancer treatment; and the ActoBiotics platform, which employs genetically modified bacteria to deliver proteins and peptides directly to mucosal sites. Precigen maintains strategic collaboration and license agreements with Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., and Intrexon Energy Partners I and II, LLC. Established in 1998, Precigen, Inc., previously known as Intrexon Corporation, adopted its current name in January 2020 and is headquartered in Germantown, Maryland.

Germantown, MD

160 employees

www.precigen.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Helen Sabzevari

View full financials

PGEN Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

57.75%

DEBT TO ASSETS RATIO AVG TTM

50.75%

DEBT TO ASSETS RATIO AVG 3Y

22.67%

DEBT TO ASSETS RATIO AVG 5Y

31.07%

DEBT TO ASSETS RATIO AVG 10Y

29.57%

DEBT TO ASSETS RATIO AVG 15Y

N/A

DEBT TO ASSETS RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+13.78%

CURRENT VS 3Y AVG

+154.74%

CURRENT VS 5Y AVG

+85.88%

CURRENT VS 10Y AVG

+95.29%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

0.09%

median of 874 covered companies

CURRENT VS SECTOR MEDIAN

+64066.05%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Precigen, Inc. (PGEN)	$2.71B	57.75%	50.75%	22.67%	31.07%
Acadia Healthcare Company, Inc. (ACHC)vs ›	$2.69B	0.46%	N/A	N/A	N/A
AtriCure, Inc. (ATRC)vs ›	$2.73B	0.11%	N/A	N/A	N/A
MBX Biosciences, Inc. Common Stock (MBX)vs ›	$2.65B	0.01%	N/A	N/A	N/A
Aveanna Healthcare Holdings Inc. (AVAH)vs ›	$2.65B	0.71%	N/A	N/A	N/A
TransMedics Group, Inc. (TMDX)vs ›	$2.78B	0.59%	N/A	N/A	N/A
Neogen Corporation (NEOG)vs ›	$2.62B	0.24%	N/A	N/A	N/A
Beam Therapeutics Inc. (BEAM)vs ›	$2.59B	0.18%	N/A	N/A	N/A
Privia Health Group, Inc. (PRVA)vs ›	$2.57B	0.01%	N/A	N/A	N/A
Dyne Therapeutics, Inc. (DYN)vs ›	$2.87B	0.02%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Precigen, Inc. (PGEN)

$2.71B

57.75%

50.75%

22.67%

31.07%

Acadia Healthcare Company, Inc. (ACHC)vs ›

$2.69B

0.46%

N/A

AtriCure, Inc. (ATRC)vs ›

$2.73B

0.11%

N/A

MBX Biosciences, Inc. Common Stock (MBX)vs ›

$2.65B

0.01%

N/A

Aveanna Healthcare Holdings Inc. (AVAH)vs ›

$2.65B

0.71%

N/A

TransMedics Group, Inc. (TMDX)vs ›

$2.78B

0.59%

N/A

Neogen Corporation (NEOG)vs ›

$2.62B

0.24%

N/A

Beam Therapeutics Inc. (BEAM)vs ›

$2.59B

0.18%

N/A

Privia Health Group, Inc. (PRVA)vs ›

$2.57B

0.01%

N/A

Dyne Therapeutics, Inc. (DYN)vs ›

$2.87B

0.02%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Precigen, Inc. (PGEN)?

The debt to assets ratio for PGEN stock is 57.75%.

Is Precigen, Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 57.75% is 86% above its 5-year average of 31.07%, near the high end of its 5-year range (3.79%–70.87%).

What is the TTM average debt to assets ratio for Precigen, Inc. (PGEN)?

The TTM average debt to assets ratio for PGEN stock is 50.75%.

What is the 3Y average debt to assets ratio for Precigen, Inc. (PGEN)?

The 3Y average debt to assets ratio for PGEN stock is 22.67%.

What is the 5Y average debt to assets ratio for Precigen, Inc. (PGEN)?

The 5Y average debt to assets ratio for PGEN stock is 31.07%.

What is the 10Y average debt to assets ratio for Precigen, Inc. (PGEN)?

The 10Y average debt to assets ratio for PGEN stock is 29.57%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	57.75%
2026-03-31	70.87%
2025-12-31	62.76%
2025-09-30	57.33%
2025-06-30	5.06%
2025-03-31	4.21%
2024-12-31	3.79%
2024-09-30	6.89%
2024-06-30	8.67%
2024-03-31	4.97%
2023-12-31	4.70%
2023-09-30	3.88%
2023-06-30	3.84%
2023-03-31	8.98%
2022-12-31	23.81%
2022-09-30	35.12%
2022-06-30	64.69%
2022-03-31	66.65%
2021-12-31	52.82%
2021-09-30	54.79%
2021-06-30	50.87%
2021-03-31	47.60%
2020-12-31	57.94%
2020-09-30	72.59%
2020-06-30	75.96%
2020-03-31	61.42%
2019-12-31	51.05%
2019-09-30	49.37%
2019-06-30	45.13%
2019-03-31	42.26%
2018-12-31	29.64%
2018-09-30	18.76%
2018-06-30	1.01%
2018-03-31	0.92%
2017-12-31	0.98%
2017-09-30	0.93%
2017-06-30	0.90%
2017-03-31	0.92%
2016-12-31	0.92%
2016-09-30	0.89%
2016-06-30	0.82%
2016-03-31	0.94%
2015-12-31	0.93%
2015-09-30	0.97%
2015-06-30	1.30%
2015-03-31	1.26%
2014-12-31	2.19%
2014-09-30	2.13%
2014-06-30	0.40%
2014-03-31	0.33%
2013-12-31	0.36%
2013-09-30	0.54%
2013-06-30	0.83%
2013-03-31	1.15%
2012-12-31	0.06%

DATE

DEBT TO ASSETS RATIO

2026-06-30

57.75%

2026-03-31

70.87%

2025-12-31

62.76%

2025-09-30

57.33%

2025-06-30

5.06%

2025-03-31

4.21%

2024-12-31

3.79%

2024-09-30

6.89%

2024-06-30

8.67%

2024-03-31

4.97%

2023-12-31

4.70%

2023-09-30

3.88%

2023-06-30

3.84%

2023-03-31

8.98%

2022-12-31

23.81%

2022-09-30

35.12%

2022-06-30

64.69%

2022-03-31

66.65%

2021-12-31

52.82%

2021-09-30

54.79%

2021-06-30

50.87%

2021-03-31

47.60%

2020-12-31

57.94%

2020-09-30

72.59%

2020-06-30

75.96%

2020-03-31

61.42%

2019-12-31

51.05%

2019-09-30

49.37%

2019-06-30

45.13%

2019-03-31

42.26%

2018-12-31

29.64%

2018-09-30

18.76%

2018-06-30

1.01%

2018-03-31

0.92%

2017-12-31

0.98%

2017-09-30

0.93%

2017-06-30

0.90%

2017-03-31

0.92%

2016-12-31

0.92%

2016-09-30

0.89%

2016-06-30

0.82%

2016-03-31

0.94%

2015-12-31

0.93%

2015-09-30

0.97%

2015-06-30

1.30%

2015-03-31

1.26%

2014-12-31

2.19%

2014-09-30

2.13%

2014-06-30

0.40%

2014-03-31

0.33%

2013-12-31

0.36%

2013-09-30

0.54%

2013-06-30

0.83%

2013-03-31

1.15%

2012-12-31

0.06%

Debt to Assets Ratio: 57.75%

PGEN Debt to Assets Ratio

PGEN Average Debt to Assets Ratio Chart

PGEN Current vs Average Debt to Assets Ratio Chart

PGEN Debt to Assets Ratio Metrics

PGEN Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

PGEN Debt to Assets Ratio History

Related Metrics